Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/25976382http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/25976382http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/25976382http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/25976382http://www.w3.org/2000/01/rdf-schema#comment"

Objectives

Deletion/insertion (Del/Ins) throughout hepatitis B virus (HBV) genome has not been well studied for HBeA-positive chronic hepatitis B (CHB) patients. This study aimed to characterize the HBV Del/Ins mutations in full-length genome quasispecies sequences in such patients at antiviral baseline and to reveal their potential impacts on HBV serological markers and responses to nucleos(t)ide analogue (NUC) treatment.

Materials and methods

A total of 30 HBeAg-positive CHB patients with genotype C infection receiving a 104-week lamivudine (LMV) and adefovir dipivoxil (ADV) combination therapy were enrolled. HBV whole genome sequences in serum samples at baseline were clone sequenced and analyzed using bioinformatics tools.

Results

Among 306 unspliced clone sequences, 61.8% (189/306) had Del/Ins mutations, 38.2% (117/306) were full-length genomes without any Del/Ins. Due to different combinations of 125 deletion types and 45 insertion types, we identified 55 Del/Ins-harboring HBV genome patterns, which affected a single or several functional genomic regions. Importantly, the proportion of Del/Ins-harboring clones was found to be significantly negatively correlated with HBsAg (r = -0.3985, P = 0.0292) and HBeAg (r = -0.3878, P = 0.0342) at baseline. Higher percentage of Del/Ins-harboring clones at baseline was found to predict a shorter interval to HBeAg loss and seroconversion.

Conclusion

Del/Ins mutations within HBV whole genome were prevalent in HBeAg-positive CHB patients prior to antiviral treatment. A higher detection rate of these mutations at baseline might correlate with a better response to LMV and ADV combination therapy."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.org/dc/terms/identifier"doi:10.1016/j.meegid.2015.05.013"xsd:string
http://purl.uniprot.org/citations/25976382http://purl.org/dc/terms/identifier"doi:10.1016/j.meegid.2015.05.013"xsd:string
http://purl.uniprot.org/citations/25976382http://purl.org/dc/terms/identifier"doi:10.1016/j.meegid.2015.05.013"xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Li T."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Li T."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Li T."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Li Y."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Li Y."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Li Y."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Su M."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Su M."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Su M."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Sun J."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Sun J."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Sun J."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Yan L."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Yan L."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Yan L."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Hou J."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Hou J."xsd:string
http://purl.uniprot.org/citations/25976382http://purl.uniprot.org/core/author"Hou J."xsd:string
▶